During the past decade, North Ohio Heart Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Ohio Heart Center" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "North Ohio Heart Center" are "Cardiovascular Disease" (2 trials), "Atherosclerosis" (1 trials), "Cardio-pulmonary Bypass" (1 trials), "Coronary Artery Bypass Graft" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "North Ohio Heart Center" in a lesser frequency.

Most popular intervention types in "North Ohio Heart Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "AGI-1067" (1 trials), "Ferric Carboxymaltose" (1 trials) and "pexelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Ohio Heart Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "North Ohio Heart Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in North Ohio Heart Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in North Ohio Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".